{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:17:04Z","timestamp":1784945824334,"version":"3.55.0"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Ophthalmol"],"DOI":"10.1001\/archopht.117.8.1087","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T02:14:18Z","timestamp":1338862458000},"page":"1087","source":"Crossref","is-referenced-by-count":38,"title":["Nephrolithiasis With Dorzolamide"],"prefix":"10.1001","volume":"117","author":[{"given":"Jeff","family":"Carlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norm","family":"Zabriskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mano","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Crandall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[1999,8,1]]},"reference":[{"key":"ref-ecr0899-1-1-1","unstructured":"JDBartlettSDJaanusClinical Ocular Pharmacology.3rd ed.Newton, MassButterworth-Heineman1995211222"},{"key":"ref-ecr0899-1-1-2","unstructured":"MWilkersonMCyrlinEALippaFour-week safety study and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.Arch Ophthalmol.199311113431350"},{"key":"ref-ecr0899-1-1-3","unstructured":"Not AvailableConsensus conference: prevention and treatment of kidney stones.JAMA.1988260977981"},{"key":"ref-ecr0899-1-1-4","unstructured":"MJGrecoOfficial release from the Associate Director of Medical Services for the manufacturer of Trusopt, dorzolamide.West Pointe, PaMerck & Co IncJuly181995"}],"container-title":["Archives of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/412217\/ecr0899.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T21:01:56Z","timestamp":1764968516000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/412217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8,1]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/archopht.117.8.1087","relation":{},"ISSN":["0003-9950"],"issn-type":[{"value":"0003-9950","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8,1]]}}}